These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791 [TBL] [Abstract][Full Text] [Related]
31. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Arbab AS; Bashaw LA; Miller BR; Jordan EK; Bulte JW; Frank JA Transplantation; 2003 Oct; 76(7):1123-30. PubMed ID: 14557764 [TBL] [Abstract][Full Text] [Related]
32. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Boutry S; Brunin S; Mahieu I; Laurent S; Vander Elst L; Muller RN Contrast Media Mol Imaging; 2008; 3(6):223-32. PubMed ID: 19072771 [TBL] [Abstract][Full Text] [Related]
33. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Pawelczyk E; Arbab AS; Chaudhry A; Balakumaran A; Robey PG; Frank JA Stem Cells; 2008 May; 26(5):1366-75. PubMed ID: 18276802 [TBL] [Abstract][Full Text] [Related]
34. Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles. Beer AJ; Holzapfel K; Neudorfer J; Piontek G; Settles M; Krönig H; Peschel C; Schlegel J; Rummeny EJ; Bernhard H Eur Radiol; 2008 Jun; 18(6):1087-95. PubMed ID: 18286290 [TBL] [Abstract][Full Text] [Related]
35. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging. Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878 [TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Lacava LM; Lacava ZG; Da Silva MF; Silva O; Chaves SB; Azevedo RB; Pelegrini F; Gansau C; Buske N; Sabolovic D; Morais PC Biophys J; 2001 May; 80(5):2483-6. PubMed ID: 11325747 [TBL] [Abstract][Full Text] [Related]
37. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Müller K; Skepper JN; Posfai M; Trivedi R; Howarth S; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH Biomaterials; 2007 Mar; 28(9):1629-42. PubMed ID: 17178155 [TBL] [Abstract][Full Text] [Related]
38. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Arbab AS; Bashaw LA; Miller BR; Jordan EK; Lewis BK; Kalish H; Frank JA Radiology; 2003 Dec; 229(3):838-46. PubMed ID: 14657318 [TBL] [Abstract][Full Text] [Related]
39. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent. Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223 [TBL] [Abstract][Full Text] [Related]
40. An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents. Bader A; Reimer P; Knop E; Böker K; Christians U; Weissleder R; Sewing KF Magn Reson Imaging; 1995; 13(7):991-1002. PubMed ID: 8583878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]